Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2005
04/07/2005WO2005030788A2 Method for conducting non-invasive early detection of colon cancer and/or of colon cancer precursor cells
04/07/2005WO2005030787A2 Oligonucleotide compositions and methods for treating disease including inflammatory conditions
04/07/2005WO2005030780A1 Fluorescent labeled sphingosines
04/07/2005WO2005030476A1 Three-dimensional gels that have microscale features
04/07/2005WO2005030269A1 Endotoxin-nonresponsive model animal
04/07/2005WO2005030139A2 Seneca valley virus based compositions and methods for treating disease
04/07/2005WO2005030041A2 Detection of hpv
04/07/2005WO2005030039A2 Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin k epoxide reductase gene and warfarin dosage
04/07/2005WO2005030028A2 Methods for detecting presence of cellular constituents
04/07/2005WO2005030027A2 Salmonella detection identification
04/07/2005WO2005019413A3 A low maintenance detector for biological agents
04/07/2005WO2005014851A3 Method and kit for assessing the risk of cardiovascular pathologies with atheromatous etiology
04/07/2005WO2005005978A3 Fluorine nmr spectroscopy for biochemical screening
04/07/2005WO2005005601A8 Compositions and methods for treating and diagnosing cancer
04/07/2005WO2005003388A3 Fluorescence assays for nucleic acid polymerase activity
04/07/2005WO2004108948A3 Systems, methods and kits for characterizing phosphoproteomes
04/07/2005WO2004102152A3 Improved porous device
04/07/2005WO2004101369A3 Selectively deformable container end closure
04/07/2005WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds
04/07/2005WO2004083371A3 Genes associated with obesity and methods for using the same
04/07/2005WO2004081224A3 Reca-assisted allele specific oligonucleotide extension method
04/07/2005WO2004081033A3 Synthesis of proteins by cell-free protein expression
04/07/2005WO2004077057A8 Standard for immunohistochemistry, immunocytochemistry and molecular cytogenetics
04/07/2005WO2004063710A8 Mark-pap system (method, kit, solution & accessories) processes for producing and using the same
04/07/2005WO2004063338A3 Methos for analyzing global regulation of coding and non-coding rna transcripts involving low molecular weight rnas
04/07/2005WO2004063324A3 Canine gene microarrays
04/07/2005WO2004052301A3 Modulation of matrix metalloproteinase 11 expression
04/07/2005WO2004046069A3 Adrenergic receptors
04/07/2005WO2004044133A3 Modified oligonucleotides for use in rna interference
04/07/2005WO2004043978A3 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
04/07/2005WO2004013309A3 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE
04/07/2005WO2004003234A3 A system and method for snp genotype clustering
04/07/2005WO2004001072A3 Method for diagnosis of colorectal tumors
04/07/2005WO2003094860A3 Use of homo sapiens chromosome 1 open reading frame 28 (c1orf28) in the diagnosis of hyperparathyroidism-jaw tumor syndrome
04/07/2005WO2003093452A3 Variants of nedd4l associated with hypertension and viral budding
04/07/2005WO2003083443A3 Lipid mediated screening of drug candidates for identification of active compounds
04/07/2005WO2003082078A3 Method and compositions for the diagnosis and treatment of non-small cell lung cancer using gene expression profiles
04/07/2005WO2003062395A3 Predictor sets for tyrosine kinase pathways
04/07/2005WO2003050290A3 Phosphoromonothioate and phosphorodithioate oligonucleotide aptamer chip for functional proteomics
04/07/2005WO2003030612A3 Methods for modulating activity of the fxr nuclear receptor
04/07/2005WO2002045659A3 Novel therapeutics for heart failure and aging
04/07/2005WO2001088089A8 Single copy genomic hybridization probes and method of generating same
04/07/2005US20050076409 Selective plant growth using d-amino acids
04/07/2005US20050076406 Plant-derived resistance gene
04/07/2005US20050076190 Method for the manipulation, storage, modeling, visualization and quantification of datasets
04/07/2005US20050075511 Prevention of human and/or animal viral, bacterial, fungal or parasitic infections; plant fungicides, bactericides and/or herbicides; reduced side effects; environmentally friendly; such as ((n-formyl-n-hydroxyamino)-methoxy)-methyl phosphonic acid disodium salt
04/07/2005US20050075495 Probes for chondrogenesis
04/07/2005US20050075494 Nucleotide sequences coding orphan receptor for use as tools in diagnosis , prevention and treatment of nervous system and psychotic disorders
04/07/2005US20050075491 Conjugating oligonucleotide with 3-substituted pyrazolo(3,4-d)pyrimidines and/or 5-substituted pyrimidine minor groove binder
04/07/2005US20050075489 DSP-5 dual-specificity phosphatase
04/07/2005US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases
04/07/2005US20050075307 Modulation of aminopeptidase N expression
04/07/2005US20050075306 Inhibition of Syk kinase expression
04/07/2005US20050075301 Pharmaceutical preparation with RNA as hemostasis cofactor
04/07/2005US20050074903 Assay method using biochemical analysis units and assay apparatus
04/07/2005US20050074889 Transcription reporter vector for use as tool in modifying phenotypic expression of cells; tissue engineering; high throughput assay
04/07/2005US20050074888 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same
04/07/2005US20050074879 Antisense oligonucleotide modulation of STAT3 expression
04/07/2005US20050074874 Unique properties of a stem cells
04/07/2005US20050074871 Bridged element for detection of a target substance
04/07/2005US20050074868 Using preferential human chromosomal sequences to determine lymphocyte linkage relationships; genetic mapping and phenotypic relationships; genomics
04/07/2005US20050074862 Polynucleotides encoding defense responde proteins
04/07/2005US20050074861 Human secretory type phospholipase A2
04/07/2005US20050074859 Nucleotide sequences coding kinesin for use in diagnosis, treatment and/or prevention of cancer, neurological and vesicular transport disorders
04/07/2005US20050074852 Serine/threonine kinase (PKN) peptides for use in identifying modulators for treatment and prevention of inflammation, cancer, arteriosclerosis and psoriasis
04/07/2005US20050074844 Using alteration in bacterial gene expression profiles as tool in determining efficacy of microbiocides
04/07/2005US20050074839 Novel survivin interacting protein tpr1
04/07/2005US20050074837 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/07/2005US20050074834 Method and system for classifying a scenario
04/07/2005US20050074833 Multiple-component integral-structure dual-test sterility indicator; screening for bacterial contamination of dry goods
04/07/2005US20050074830 Screening method for an agent having an affect on a sphingosine kinase signaling pathway
04/07/2005US20050074829 Methods for identifying inhibitors of sterol 14-alpha-demethylase
04/07/2005US20050074828 Uae of lipase for high-density lipoprotein cholesterol detection
04/07/2005US20050074827 Methods for identifying modulators of quorum-sensing signaling in bacteria
04/07/2005US20050074824 Quantification and site-specific profiling of protein phosphorylation
04/07/2005US20050074819 Using ligand gated channel protein to identify modulators for prevention and treatment of tactile allodynia induced after nerve injury
04/07/2005US20050074815 Bioassays incorporate film with chemiluminescent precursor immobilized therewith; polynucleotide/DNA analysis; kits
04/07/2005US20050074806 Methods of genetic cluster analysis and uses thereof
04/07/2005US20050074805 Specific markers for diabetes
04/07/2005US20050074804 Propagating/replicating preferential nucleotide/gene sequences using circular plasmid; genetic engineering and heterologous gene expression
04/07/2005US20050074801 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry
04/07/2005US20050074800 Using tartrate-resistant acid phosphatase activity as diagnostic indicator of degenerative ligament disease; bioassay
04/07/2005US20050074799 Use of guanine analogs in high-complexity genotyping
04/07/2005US20050074797 FHIT proteins and nucleic acids and methods based thereon
04/07/2005US20050074796 Comprises benzazolium, pyridinium, or quinolinium connected by methine bridge; reporter molecules for detection of RNA in presence of DNA; solid phase synthesis; kits
04/07/2005US20050074795 Computerized method and system for automated correlation of genetic test results
04/07/2005US20050074794 labeling proteins and other molecules such as lipid and carbohydrates in different samples, then combining these samples for concurrent analysis, for reliable qualitative and quantitative comparison between the samples
04/07/2005US20050074793 Metastatic colorectal cancer signatures
04/07/2005US20050074792 Storing and detecting nucleic acid administered to a solid carrier
04/07/2005US20050074789 Using immobilized probes to isolate preferential nucleotide sequences; high-resolution information for individual genotypes; disease diagnosis and pharmaceutical efficacy
04/07/2005US20050074788 Detection of small nucleic acids
04/07/2005US20050074787 Universal arrays
04/07/2005US20050074786 Using variation in ligand activated transcription factor as tool in diagnosing and prognosing cardiovascular disorders
04/07/2005US20050074784 Microchip bioarray for detection and identification of chemical and biological agent; screening biological/chemical warfare agents
04/07/2005US20050074782 Using multicompatrment rayleigh-benard convection cell as tool for running and monitoring biological reaction and assays
04/07/2005US20050074781 Nucleic acid braided J-probes
04/07/2005US20050074779 Oligonucleotide-based surface-enhanced raman spectroscopy for use as tool in detection and treatment of cell proliferative disorders
04/07/2005US20050074778 Constructed on glass, carbon, and/or semiconductor substrates
04/07/2005US20050074777 Novel cell-surface estrogen receptor and related compositions and methods
04/07/2005US20050074775 assessing GST-pi expression levels in fixed or fixed and paraffin embedded tissues using primers; pharmacogenetics; determining antitumor platinum-based chemotherapeutic regimen